Skip to main content

Day: September 29, 2025

CLINUVEL to advance novel pharmaceutical formulations in preclinical program

Next generation sustained-release formulations for a variety of peptides Executive summaryfirst biocompatible pharmaceutical formulations progress to preclinical models new sustained-release drug delivery platforms for peptides, melanocortins aim to predict drug release kinetics from new formulations liquid formulation allows flexible dosing through adjusting injection volumes perseverance during 10 years of in-house researchMELBOURNE, Australia, Sept. 28, 2025 (GLOBE NEWSWIRE) — CLINUVEL today announced that it is advancing new sustained-release liquid drug formulations in a preclinical program evaluating various drug release profiles. A decade of investment in fundamental research & development in CLINUVEL’s fully-owned Singaporean laboratories (VALLAURIX) has provided positive, consistent results demonstrating the potential...

Continue reading

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX 4 Product Execution Plan Announced, will be the First Potential Model Under the FX Brand Designed for the Volume Market

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX 4 Product Execution Plan Announced, will be the First Potential Model Under the FX Brand Designed for the Volume MarketFaraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX 4 Product Execution Plan Announced, will be the First Potential Model Under the FX Brand Designed for the Volume MarketFX Super One Middle East Final Launch event will be held on October 28, start of the first deliveries in the Middle East planned for November of this year. FF and FX will join WETEX 2025 in Dubai from September 30 to October 2, one of the largest and most influential exhibitions for sustainable and clean energy in the Middle East.LOS ANGELES, Sept. 28, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.